Brookstone Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.55M | Buy |
|
|||||
|
2025
Q2 | $1.39M | Sell |
|
|||||
|
2025
Q1 | $1.35M | Buy |
|
|||||
|
2024
Q4 | $1.16M | Buy |
|
|||||
|
2024
Q3 | $1.35M | Sell |
|
|||||
|
2024
Q2 | $1.33M | Sell |
|
|||||
|
2024
Q1 | $1.24M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $1.13M | Buy |
|
|||||
|
2023
Q2 | $1.12M | Sell |
|
|||||
|
2023
Q1 | $1.69M | Sell |
|
|||||
|
2022
Q4 | $1.69M | Sell |
|
|||||
|
2022
Q3 | $1.38M | Sell |
|
|||||
|
2022
Q2 | $1.56M | Buy |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2021
Q3 | $859K | Buy |
|
|||||
|
2021
Q2 | $943K | Buy |
|
|||||
|
2021
Q1 | $691K | Buy |
|
|||||
|
2020
Q4 | $752K | Sell |
|
|||||
|
2020
Q3 | $700K | Sell |
|
|||||
|
2020
Q2 | $743K | Buy |
|
|||||
|
2020
Q1 | $225K | Sell |
|
|||||
|
2019
Q4 | $267K | Buy |
|
|||||
|
2019
Q3 | $211K | Sell |
|
|||||
|
2019
Q2 | $235K | Buy |
|
|||||
|
2019
Q1 | $220K | Sell |
|
|||||
|
2018
Q4 | $218K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $207K | Sell |
|
|||||
|
2017
Q4 | $229K | Sell |
|
|||||
|
2017
Q3 | $258K | Buy |
|
|||||
|
2017
Q2 | $245K | Buy |
|
|||||
|
2017
Q1 | $215K | Sell |
|
|||||
|
2016
Q4 | $220K | Sell |
|
|||||
|
2016
Q3 | $252K | Sell |
|
|||||
|
2016
Q2 | $266K | Buy |
|
|||||
|
2016
Q1 | $207K | Sell |
|
|||||
|
2015
Q4 | $317K | Buy |
|
|||||
|
2015
Q3 | $320K | Sell |
|
|||||
|
2015
Q2 | $513K | Sell |
|
|||||
|
2015
Q1 | $670K | Buy |
|
|||||
|
2014
Q4 | $405K | Buy |
|
|||||
|
2014
Q3 | $326K | Buy |
|
|||||
|
2014
Q2 | $266K | Buy |
|